Loise Ndung’u

Amodiaquine Resistance in Plasmodium Berghei is Associated with Pbcrt His95Pro Mutation, Loss of Chloroquine, Artemisinin and Primaquine Sensitivity, and High Transcript Levels of Key Transporters [Version 2; Referees: 3 Approved]

A. Nzila, B. Langat, D. Kiboi, 2018 .

Amodiaquine resistance in Plasmodium berghei is associated with PbCRT His95Pro mutation, loss of chloroquine, artemisinin and primaquine sensitivity, and high transcript levels of key transporters

A. Nzila, B. Langat, D. Kiboi, 2017, Wellcome open research.

Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei

D. Matoke-Muhia, D. Kiboi, F. Kimani, 2018, bioRxiv.

Genetic alteration of ferredoxin NADP+-reductase or cysteine desulfurase in piperaquine-resistant Plasmodium berghei restores susceptibility to lumefantrine and abolishes the impact of probenecid, verapamil, and cyproheptadine

A. Nzila, D. Matoke-Muhia, D. Kiboi, 2020 .

Efficacy of Lumefantrine against piperaquine resistant Plasmodium berghei parasites is selectively restored by probenecid, verapamil, and cyproheptadine through ferredoxin NADP+-reductase and cysteine desulfurase

A. Nzila, D. Matoke-Muhia, D. Kiboi, 2019 .

Short title: Mechanisms of Lumefantrine resistance and reversal in Plasmodium berghei ANKA

A. Nzila, D. Matoke-Muhia, D. Kiboi, 2020 .